References
Mitka M. US government kicks off program for comparative effectiveness research. JAMA 2010; 304: 2230–1
Mushlin AI, Ghomrawi H. Health care reform and the need for comparative-effectiveness research. N Engl J Med 2010; 362: e6
Weinstein M, Skinner J. Comparative effectiveness and health care spending: implications for reform. N Engl J Med 2010; 362: 460–5
Sox H. Comparative effectiveness research: a progress report. Ann Intern Med 2010; 153: 469–72
Sox H, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2009; 151: 203–5
Sox H. Defining comparative effectiveness research: the importance of getting it right. Med Care 2010; 48 (6 Suppl.): S7–8
Garber A, Tunis S. Does comparative-effectiveness research threaten personalized medicine? N Engl J Med 2009; 360: 1925–7
Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2006; 58(4): 323–37
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–97
Avorn J. Debate about funding comparative-effectiveness research. N Engl J Med 2009; 360: 1927–9
Iglehart J. The political fight over comparative effectiveness research. Health Aff (Millwood) 2010; 29: 1757–60
Meltzer D, Detsky A. The real meaning of rationing. JAMA 2010; 304: 2292–3
Owens D, Qaseem A, Chou R, et al. High-value, cost-conscious health care: concepts for clinicians to evaluate benefits, harms, and costs of medical interventions. Ann Intern Med 2011; 154(3): 174–80
Clement F, Harris A, Li J, et al. Using effectiveness and cost-effectiveness to make drug coverage decisions. JAMA 2009; 302: 1437–43
Atkins D, Siegel J, Slutsky J. Making policy when the evidence is in dispute. Health Aff (Millwood) 2005; 24: 102–13
Neumann P, Weinstein M. Legislating against use of cost-effectiveness information. N Engl J Med 2010; 363: 1495–7
Wilensky G. Cost-effectiveness information: yes it’s important, but keep it separate, please. Ann Intern Med 2008; 148: 967–8
Wong J, Mulrow C, Sox H. Health policy and cost-effectiveness analysis: yes we can. Yes we must. Ann Intern Med 2009; 150: 274–5
Acknowledgements
No funding was received for this work. The author has received research funding from the Agency for Healthcare Research and Quality, the Drug Effectiveness Research Project and the American Pain Society, and has consulted for Consumer’s Union, Wellpoint, the Blue Cross Blue Shield Association and Palladian Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chou, R. Comparative Effectiveness Research. Drugs 71, 383–386 (2011). https://doi.org/10.2165/11585410-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11585410-000000000-00000